A new imaging technology can distinguish cancerous tissue from healthy cells by detecting ultra-weak light signals. It relies ...

SYDNEY, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology ...

Rocket Lab launched its 21st and final mission of the year over the weekend, sending a private Japanese Earth-observing ...

92% of evaluable patients at interim analysis treated with RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in suspected or recurrent ...

Rocket Lab Corporation (NASDAQ: RKLB) stock rose Wednesday after the company advanced a South Korean Earth-imaging mission into its next available launch window. The move comes as broader investor ...

Radiopharm Theranostics Limited (NASDAQ: RADX) stock is trading higher on Monday, with a session volume of 21.33 million compared to the average volume of 26.81 thousand, as per data from Benzinga Pro ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses about the answer to this question.

Despite major therapeutic advances, breast cancer remains prone to recurrence, particularly in patients with early-stage ...

IntroductionThe global critical care diagnostics market is poised for steady expansion, projected to grow at a CAGR of around 6% over the next five years. This growth trajectory is supported by ...